✦ LIBER ✦

Mutational Analysis and Overcoming Imatinib Resistance in Chronic Myeloid Leukemia with Novel Tyrosine Kinase Inhibitors

✍ Scribed by Michael J. Mauro

Book ID: 107531998
Publisher: Springer
Year: 2007
Tongue: English
Weight: 155 KB
Volume: 8
Category: Article
ISSN: 1527-2729
DOI: 10.1007/s11864-007-0036-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stem cell transplantation for patients w

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I

✍ Nikolai Velev; Jorge Cortes; Richard Champlin; Dan Jones; Gabriela Rondon; Sergi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Complexity of BCR-ABL kinase domain muta

Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemia

✍ Dushyant Verma; Carmen Fava; Hagop Kantarjian; Jorge Cortes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Practical advice for determining the rol

Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

✍ Elias Jabbour; Susan Branford; Giuseppe Saglio; Dan Jones; Jorge E. Cortes; Hago 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 1 views

## Abstract Data demonstrating the superiority of nilotinib over imatinib in the frontline treatment of chronic myeloid leukemia (CML) and ongoing studies with dasatinib and bosutinib are rapidly changing the treatment landscape for CML. In this review, the authors discuss currently available thera

T cell function in chronic myeloid leuke

T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors—Clues from and for sarcoidosis

✍ Maqsood Punekar; Jecko Thachil; Rahuman Salim; Sara Watmough; Richard E. Clark 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Renal failure and recovery associated wi

Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia

✍ Sarah A. Holstein; John B. Stokes; Raymond J. Hohl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Absolute quantitative detection of ABL t

Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR

✍ Oehler, V G; Qin, J; Ramakrishnan, R; Facer, G; Ananthnarayan, S; Cummings, C; D 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB